These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 26906339)

  • 1. Risk assessment and management to prevent preterm birth.
    Koullali B; Oudijk MA; Nijman TA; Mol BW; Pajkrt E
    Semin Fetal Neonatal Med; 2016 Apr; 21(2):80-8. PubMed ID: 26906339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prevention of spontaneous preterm birth (excluding preterm premature rupture of membranes): Guidelines for clinical practice - Text of the Guidelines (short text)].
    Sentilhes L; Sénat MV; Ancel PY; Azria E; Benoist G; Blanc J; Brabant G; Bretelle F; Brun S; Doret M; Ducroux-Schouwey C; Evrard A; Kayem G; Maisonneuve E; Marcellin L; Marret S; Mottet N; Paysant S; Riethmuller D; Rozenberg P; Schmitz T; Torchin H; Langer B
    J Gynecol Obstet Biol Reprod (Paris); 2016 Dec; 45(10):1446-1456. PubMed ID: 27836377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Routine second trimester cervical length screening in low risk women identified women at risk of a 'very' preterm birth but did not reduce the preterm birth rate: a randomised study from India.
    Mishra S; Bagga R; Kalra J; Jain V; Dutta S
    J Obstet Gynaecol; 2018 Aug; 38(6):789-795. PubMed ID: 29537316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of spontaneous preterm birth: Guidelines for clinical practice from the French College of Gynaecologists and Obstetricians (CNGOF).
    Sentilhes L; Sénat MV; Ancel PY; Azria E; Benoist G; Blanc J; Brabant G; Bretelle F; Brun S; Doret M; Ducroux-Schouwey C; Evrard A; Kayem G; Maisonneuve E; Marcellin L; Marret S; Mottet N; Paysant S; Riethmuller D; Rozenberg P; Schmitz T; Torchin H; Langer B
    Eur J Obstet Gynecol Reprod Biol; 2017 Mar; 210():217-224. PubMed ID: 28068594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for preterm delivery: do they add to fetal fibronectin testing and cervical length measurement in the prediction of preterm delivery in symptomatic women?
    van Baaren GJ; Bruijn MM; Vis JY; Wilms FF; Oudijk MA; Kwee A; Porath MM; Oei G; Scheepers HC; Spaanderman ME; Bloemenkamp KW; Haak MC; Bolte AC; Bax CJ; Cornette JM; Duvekot JJ; Nij Bijvanck BW; van Eijck J; Franssen MT; Sollie KM; Vandenbussche FP; Woiski M; Bossuyt PM; Opmeer BC; Mol BW
    Eur J Obstet Gynecol Reprod Biol; 2015 Sep; 192():79-85. PubMed ID: 26182836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple gestations and preterm birth.
    Fuchs F; Senat MV
    Semin Fetal Neonatal Med; 2016 Apr; 21(2):113-20. PubMed ID: 26795885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting preterm birth: Cervical length and fetal fibronectin.
    Son M; Miller ES
    Semin Perinatol; 2017 Dec; 41(8):445-451. PubMed ID: 28935263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes and predictive tests from a dedicated specialist clinic for women at high risk of preterm labour: A ten year audit.
    Hughes K; Sim S; Roman A; Michalak K; Kane S; Sheehan P
    Aust N Z J Obstet Gynaecol; 2017 Aug; 57(4):405-411. PubMed ID: 28349516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The predictive value of quantitative fibronectin testing in combination with cervical length measurement in symptomatic women.
    Bruijn MM; Kamphuis EI; Hoesli IM; Martinez de Tejada B; Loccufier AR; Kühnert M; Helmer H; Franz M; Porath MM; Oudijk MA; Jacquemyn Y; Schulzke SM; Vetter G; Hoste G; Vis JY; Kok M; Mol BW; van Baaren GJ
    Am J Obstet Gynecol; 2016 Dec; 215(6):793.e1-793.e8. PubMed ID: 27542720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transvaginal ultrasonographic measurement of cervical length in asymptomatic high-risk women with a short cervical length in the previous pregnancy.
    Crane JM; Hutchens D
    Ultrasound Obstet Gynecol; 2011 Jul; 38(1):38-43. PubMed ID: 21425200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of a cervical pessary for women who did not deliver 48 h after threatened preterm labor (Assessment of perinatal outcome after specific treatment in early labor: Apostel VI trial).
    Hermans FJ; Schuit E; Opmeer BC; Oudijk MA; Bekker M; Woiski M; Bax CJ; Sueters M; Scheepers HC; Franssen MT; Pajkrt E; Mol BW; Kok M
    BMC Pregnancy Childbirth; 2016 Jul; 16(1):154. PubMed ID: 27405353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Follow-up cervical length in asymptomatic high-risk women and the risk of spontaneous preterm birth.
    Crane JM; Hutchens D
    J Perinatol; 2011 May; 31(5):318-23. PubMed ID: 21183925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Predictive tools of preterm birth in asymptomatic high-risk pregnancy].
    Blanc J; Bretelle F
    J Gynecol Obstet Biol Reprod (Paris); 2016 Dec; 45(10):1261-1279. PubMed ID: 28029460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pessary or Progesterone to Prevent Preterm delivery in women with short cervical length: the Quadruple P randomised controlled trial.
    van Zijl MD; Koullali B; Naaktgeboren CA; Schuit E; Bekedam DJ; Moll E; Oudijk MA; van Baal WM; de Boer MA; Visser H; van Drongelen J; van de Made FW; Vollebregt KC; Muller MA; Bekker MN; Brons JTJ; Sueters M; Langenveld J; Franssen MT; Schuitemaker NW; van Beek E; Scheepers HCJ; de Boer K; Tepe EM; Huisjes AJM; Hooker AB; Verheijen ECJ; Papatsonis DN; Mol BWJ; Kazemier BM; Pajkrt E
    BMC Pregnancy Childbirth; 2017 Sep; 17(1):284. PubMed ID: 28870155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of additive effect of quantitative fetal fibronectin to cervical length for prediction of spontaneous preterm birth among asymptomatic low-risk women.
    Jwala S; Tran TL; Terenna C; McGregor A; Andrel J; Leiby BE; Baxter JK; Berghella V
    Acta Obstet Gynecol Scand; 2016 Aug; 95(8):948-55. PubMed ID: 27100022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevention of spontaneous preterm birth in asymptomatic twin pregnancies].
    Sentilhes L; Bouhours AC; Bouet PE; Boussion F; Biquard F; Gillard P; Descamps P
    J Gynecol Obstet Biol Reprod (Paris); 2009 Dec; 38(8 Suppl):S61-75. PubMed ID: 20141930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular and biochemical mechanisms, risk factors and management of preterm birth: state of the art.
    Vitale SG; Marilli I; Rapisarda AM; Rossetti D; Belluomo G; Iapichino V; Stancanelli F; Cianci A
    Minerva Ginecol; 2014 Dec; 66(6):589-95. PubMed ID: 25373016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaginal progesterone decreases preterm birth ≤ 34 weeks of gestation in women with a singleton pregnancy and a short cervix: an updated meta-analysis including data from the OPPTIMUM study.
    Romero R; Nicolaides KH; Conde-Agudelo A; O'Brien JM; Cetingoz E; Da Fonseca E; Creasy GW; Hassan SS
    Ultrasound Obstet Gynecol; 2016 Sep; 48(3):308-17. PubMed ID: 27444208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of routine cervical length screening in selected high- and low-risk women for preterm birth prevention.
    ; McIntosh J; Feltovich H; Berghella V; Manuck T
    Am J Obstet Gynecol; 2016 Sep; 215(3):B2-7. PubMed ID: 27133011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Routine Use of an Antenatal Infection Screen-and-Treat Program to Prevent Preterm Birth: Long-Term Experience at a Tertiary Referral Center.
    Farr A; Kiss H; Hagmann M; Marschalek J; Husslein P; Petricevic L
    Birth; 2015 Jun; 42(2):173-80. PubMed ID: 25677078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.